Related Experiment Video
Updated: May 8, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Hematologic complications of pregnancy
1National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. Danielle.townsley@nih.gov
Seminars in Hematology
|August 20, 2013
Summary
Pregnancy causes hematologic changes, complicating diagnosis and treatment of blood disorders like anemia and thrombocytopenia. This review guides management of these conditions, including venous thromboembolism (VTE), for improved maternal and infant outcomes.
Area of Science:
- Hematology
- Obstetrics
- Maternal-Fetal Medicine
Background:
- Pregnancy significantly alters hematologic indices, presenting diagnostic and therapeutic challenges due to limited evidence.
- Benign hematologic disorders are common during pregnancy, requiring careful management to ensure maternal and fetal well-being.
Purpose of the Study:
- To review the diagnosis and management of benign hematologic disorders encountered during pregnancy.
- To provide guidance for healthcare providers managing hematologic complications in pregnant patients.
Main Methods:
- Literature review focusing on diagnosis and treatment strategies for common hematologic issues in pregnancy.
- Discussion of specific conditions including anemia, thrombocytopenia, bleeding disorders, and venous thromboembolism (VTE).
Main Results:
- Iron deficiency anemia is the most frequent complication, typically managed with oral iron.
- Distinguishing gestational thrombocytopenia from other causes like immune thrombocytopenia (ITP) and HELLP syndrome is crucial.
- Neonatal alloimmune thrombocytopenia (NAIT) requires prompt recognition for severe neonatal bleeding.
- Inherited/acquired bleeding disorders and VTE pose significant risks, necessitating coagulation monitoring and preventive strategies.
Conclusions:
- Effective management of hematologic disorders during pregnancy requires accurate diagnosis and tailored treatment approaches.
- Addressing anemia, thrombocytopenia, bleeding risks, and VTE is essential for optimizing pregnancy outcomes.
- Further research is needed to expand the evidence base for managing hematologic conditions in pregnancy.
Related Concept Videos
01:19Rh Blood Group
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
01:24Hemodialysis II: Procedure and Complications
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...